Chemoprotective effect of sobatum against cyclophosphamide toxicity in mice

Journal of Experimental and Clinical Cancer Research

Volumn 17, Issue 2, 1998, Pages 159-164

  Mohanan, P V ^a   Devi, K S ^b  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

^b UNIVERSITY OF KERALA   (India)

Author keywords

Chemoprotection; Cytotoxic; Haemoglobin; Leucocytes

Indexed keywords

CYCLOPHOSPHAMIDE; SOLANUM ALKALOID;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ASCITES TUMOR; CANCER CELL CULTURE; CARCINOGENESIS; CHROMOSOME ABERRATION; CONTROLLED STUDY; EHRLICH ASCITES TUMOR; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; LYMPHOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; BODY WEIGHT; CYCLOPHOSPHAMIDE; DRUG INTERACTIONS; HEMOGLOBINS; LEUKOCYTE COUNT; MICE; PLANT EXTRACTS;

EID: 0031812655     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Mohanan P.V.: Toxicological/Safety evaluation of an anticancer drug. Ph. D. Thesis, Kerala University, Kerala, India, 1996.
2. Mohanan P.V., Devi K.S.: Cytotoxic potential of the preparations from Solanum trilobatum and the effect of Sobatum on tumor reduction in mice. Cancer Lett. 110: 71-76, 1996.
3. Mohanan P.V., Devi K.S.: Effect of Sobatum on tumor development and chemically induced carcinogenesis. Cancer Lett. 112: 219-223, 1997.
4. Mohanan P.V., Rathinam K., Devi K.S.: Effect of Sobatum on Ultra violet induced damage and superoxide production. Ind. J. Pharmacol. 29: 129-131, 1997.
5. Huang M.T., Smart C.R., Wong C.Q., Conney A.H.: Inhibitory effect of curcumin, chlorogenic acid, and ferulic acid on tumour promotion in mouse skin by 12-0-Tetradecanoyl phorbol-13-acetate. Cancer Res. 48: 5941-5946, 1998.
6. Nagabhushan M., Bhide S.V.: Antimutagenicity and anticarcinogenicity of turmeric (Curcuma longa). J. Nutr. Growth Care 4: 83-89, 1987.
7. Mohanan P.V., Rathinam K., Devi K.S.: Lack of micronuleus induction by Sobatum in bone marrow erythrocytes of swiss mice. Mutation Res. 361: 23-27, 1996.
8. Salzer R., Harlec L.: Prophylactic treatment agaist recurrences in cases of operated carcinoma of bronchial tree with the misletoe preparation, Iscador, Oncology 1: 264-266, 1978.
9. Nair S.C., Solomi M.J., Panikkar K.R.: Chemoprotective effect of some natural products. Proc. Natl. Semo. Cancer 1: 28-30, 1990.
10. Wilcox W.S., Griswold D.P., Laster W.R., Schabel F.W. Jr., Skipper H.E.: Experimental evaluation of potential anticancer agents. XVII. Kinetics of growth and regression after treatment of certain solid tumours. Cancer Chemotherapy Rep. 47: 27-39, 1965.
11. International Committee for standardisation in haematology. B.J. Haematol. 13 (suppl): 168, 1967.
12. Sauhami R.L., Harper P.G., Linch D., Traske., Goldstone A.H., Richards J.D.: High dose of cyclophosphamide with autologus marrow transplantation as initial treatment of small cell carcinoma of the bronchus. Cancer Chemother Pharmacol. 8: 31-34, 1982.
13. Sladek N.E., Landkamer G.J.: Restoration of sensitivity to oxanzaphosphorines by inhibitors of aldehyde dehydrogenase activity on cultured oxazophorine resistant L1210 and cross linking against resistant. Cancer Res. 45: 1549-1555, 1985.
14. Wrabtz E., Peter G., Rohorst H.J.: Does Acrolein contribute to the cytotoxicity of cyclophosphamide. J. Cancer Res. Clin. Oncol. 98: 119-126, 1986.